First Trust Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,896
| Closed | -$41.9K | – | 2597 |
|
|
2024
Q4 | $41.9K | Buy |
+22,896
| New | +$41.9K | ﹤0.01% | 2545 |
|
|
2024
Q2 | – | Sell |
-39,974
| Closed | -$150K | – | 2397 |
|
|
2024
Q1 | $150K | Buy |
39,974
+25,366
| +174% | +$95.1K | ﹤0.01% | 2293 |
|
|
2023
Q4 | $143K | Sell |
14,608
-191,663
| -93% | -$1.88M | ﹤0.01% | 2317 |
|
|
2023
Q3 | $1.72M | Buy |
206,271
+1,492
| +0.7% | +$12.5K | ﹤0.01% | 1745 |
|
|
2023
Q2 | $2.72M | Buy |
+204,779
| New | +$2.72M | ﹤0.01% | 1558 |
|
|
2021
Q4 | – | Sell |
-114,037
| Closed | -$2.91M | – | 2577 |
|
|
2021
Q3 | $2.91M | Sell |
114,037
-34,223
| -23% | -$875K | ﹤0.01% | 1612 |
|
|
2021
Q2 | $5.19M | Buy |
+148,260
| New | +$5.19M | 0.01% | 1338 |
|
|
2017
Q1 | – | Sell |
-97,396
| Closed | -$370K | – | 2438 |
|
|
2016
Q4 | $370K | Buy |
+97,396
| New | +$370K | ﹤0.01% | 2220 |
|
|
2016
Q3 | – | Sell |
-127,934
| Closed | -$900K | – | 2374 |
|
|
2016
Q2 | $900K | Buy |
+127,934
| New | +$900K | ﹤0.01% | 1759 |
|